Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report)’s share price was up 1.8% during trading on Wednesday . The stock traded as high as $0.52 and last traded at $0.52. Approximately 7,700 shares traded hands during trading, a decline of 44% from the average daily volume of 13,844 shares. The stock had previously closed at $0.52.
Spectral Medical Price Performance
The stock has a market capitalization of $148.07 million, a price-to-earnings ratio of -7.43 and a beta of 0.84. The firm has a fifty day moving average of $0.45 and a 200 day moving average of $0.42.
Spectral Medical Company Profile
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Further Reading
- Five stocks we like better than Spectral Medical
- Stock Market Upgrades: What Are They?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Top Biotech Stocks: Exploring Innovation Opportunities
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Invest in Biotech Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
